EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 43 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $495,000 | -27.9% | 55,900 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $687,000 | +47.7% | 55,900 | -2.1% | 0.00% | – |
Q3 2020 | $465,000 | -6.8% | 57,100 | +9.8% | 0.00% | – |
Q2 2020 | $499,000 | +41.0% | 52,023 | -0.2% | 0.00% | – |
Q1 2020 | $354,000 | -45.6% | 52,123 | +19.2% | 0.00% | -100.0% |
Q4 2019 | $651,000 | +342.9% | 43,723 | +205.3% | 0.00% | – |
Q3 2019 | $147,000 | -14.0% | 14,323 | -11.2% | 0.00% | – |
Q2 2019 | $171,000 | +22.1% | 16,131 | +61.3% | 0.00% | – |
Q1 2019 | $140,000 | +37.3% | 10,000 | 0.0% | 0.00% | – |
Q4 2018 | $102,000 | -15.0% | 10,000 | 0.0% | 0.00% | – |
Q3 2018 | $120,000 | -1.6% | 10,000 | 0.0% | 0.00% | – |
Q2 2018 | $122,000 | +23.2% | 10,000 | 0.0% | 0.00% | – |
Q1 2018 | $99,000 | -29.3% | 10,000 | 0.0% | 0.00% | – |
Q4 2017 | $140,000 | +27.3% | 10,000 | 0.0% | 0.00% | – |
Q3 2017 | $110,000 | +39.2% | 10,000 | 0.0% | 0.00% | – |
Q2 2017 | $79,000 | -31.3% | 10,000 | 0.0% | 0.00% | – |
Q1 2017 | $115,000 | -1.7% | 10,000 | 0.0% | 0.00% | – |
Q4 2016 | $117,000 | -12.7% | 10,000 | 0.0% | 0.00% | – |
Q3 2016 | $134,000 | -32.3% | 10,000 | 0.0% | 0.00% | – |
Q2 2016 | $198,000 | +17.9% | 10,000 | 0.0% | 0.00% | – |
Q1 2016 | $168,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |